Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 11/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | NPY1R | P25929 | 1/20 | 0.31 |
| ▸ | NPY2R | P49146 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7753531 | 1.00 | SLC6A9 (0.38) | SLC6A9CYP11B1CYP11B2ALDH1A1LMNA | |
| SCHEMBL7755650 | 0.90 | SLC6A9 (0.35) | SLC6A9ALDH1A1LMNAHPGDTP53 | |
| SCHEMBL7755652 | 0.90 | SLC6A9 (0.35) | SLC6A9ALDH1A1LMNAHPGDTP53 | |
| SCHEMBL7754296 | 0.89 | SLC6A9 (0.34) | SLC6A9ALDH1A1LMNAHPGDTP53 | |
| SCHEMBL7754303 | 0.89 | SLC6A9 (0.34) | SLC6A9ALDH1A1LMNAHPGDTP53 | |
| SCHEMBL7753227 | 0.86 | CYP11B1 (0.38) | CYP11B1CYP11B2 | |
| SCHEMBL7753234 | 0.86 | CYP11B1 (0.38) | CYP11B1CYP11B2 | |
| SCHEMBL7753592 | 0.78 | CYP11B1 (0.32) | CYP11B1CYP11B2ALDH1A1LMNAHPGD | |
| SCHEMBL7753598 | 0.78 | CYP11B1 (0.32) | CYP11B1CYP11B2ALDH1A1LMNAHPGD | |
| SCHEMBL7755699 | 0.75 | SLC6A9 (0.38) | SLC6A9ALDH1A1LMNAHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010029239-A1 | New herbicidal compositions | CRAMP MICHAEL COLIN (GB) | 2001-10-11 | — | — | US | disclosed |
| WO-2001047863-A2 | NEW HERBICIDAL COMPOSITIONS | AVENTIS CROPSCIENCE SA (FR) | 2001-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010029239-A1 | New herbicidal compositions | DDT, CYP1B1, CYP4X1 | SLC6A9 1897/4885CYP11B1 342/4885CYP11B2 588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.